Danielle Ulanet
Xilio Therapeutics (United States)
ORCID: 0009-0001-7754-9224Biochemistry, Genetics and Molecular BiologyMedicine
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 2 papers. Top paper: “Post-therapy emergence of an NBN reversion mutation in a patient with pancreatic acinar cell carcinoma”.
4 citations
Ian M. Silverman, Joseph D. Schonhoft, Adrienne Johnson, Pier Selenica, Danielle Ulanet +3 more
3 citations
Ian M. Silverman, Adrienne Johnson, Chenfeng Meng, Joseph D. Schonhoft, Michal Zimmermann +10 more